Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 40/100

Failure Rate

12.0%

6 terminated/withdrawn out of 50 trials

Success Rate

86.0%

-0.5% vs industry average

Late-Stage Pipeline

36%

18 trials in Phase 3/4

Results Transparency

5%

2 of 37 completed trials have results

Key Signals

1 recruiting2 with results4 withdrawn

Enrollment Performance

Analytics

Phase 4
10(30.3%)
N/A
9(27.3%)
Phase 3
8(24.2%)
Phase 2
6(18.2%)
33Total
Phase 4(10)
N/A(9)
Phase 3(8)
Phase 2(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (50)

Showing 20 of 50 trials
NCT06841614Phase 3Not Yet Recruiting

EBOla Post-Exposure Prophylaxis

Role: collaborator

NCT04268524Phase 3Recruiting

Randomised Clinical Trial for New Treatment Modalities for Cutaneous Leishmaniasis Caused by Leishmania Tropica, in Pakistan

Role: lead

NCT05449717Completed

Incidence of Relapse and Post-Kala-Azar Dermal Leishmaniasis in South Sudan

Role: collaborator

NCT03851588Phase 2Completed

Standard Versus Double Dose Dolutegravir in Patients With HIV-associated Tuberculosis

Role: collaborator

NCT03942354Completed

Patient-reported Experiences and Quality of Life Outcomes in the TB-PRACTECAL Clinical Trial

Role: lead

NCT02589782Phase 2Completed

Pragmatic Clinical Trial for a More Effective Concise and Less Toxic MDR-TB Treatment Regimen(s)

Role: lead

NCT04207112Phase 2Completed

Economic Evaluation of New MDR TB Regimens

Role: lead

NCT02145000Phase 3Completed

Efficacy and Safety of a Pentavalent Rotavirus Vaccine (BRV-PV) Against Severe Rotavirus Gastroenteritis in Niger

Role: collaborator

NCT05075941Completed

Evaluation of Vaccination Coverage and Determinants of Success of the COVID-19 Vaccination Program Among Populations in Very Precarious Situations

Role: collaborator

NCT03827811Unknown

Pharmacometrics to Advance Novel Regimens for Drug-resistant Tuberculosis-PandrTB Tuberculosis

Role: collaborator

NCT03013673Terminated

Predicting Visceral Leishmaniasis in HIV Infected Patients

Role: collaborator

NCT00495508Phase 4Completed

Quinine vs. Artemether/Lumefantrine in Uncomplicated Malaria During Pregnancy

Role: collaborator

NCT04331847Unknown

Abortion-related Morbidity and Mortality in Conflict-affected and Fragile Settings Study

Role: collaborator

NCT04932837Withdrawn

Level of Immunity, Neutralization of the COVID-19 Virus and Reinfections in Residents of 2 Migrant Workers' Residences

Role: collaborator

NCT04081077Phase 2Unknown

PRACTECAL-PKPD Sub Study

Role: lead

NCT03431675Phase 4Withdrawn

Ciprofloxacin for the Prevention of Meningococcal Meningitis 2018

Role: collaborator

NCT03360877Not ApplicableCompleted

Prevention of Nosocomial Infections (CleanKids)

Role: collaborator

NCT02011958Phase 3Completed

Efficacy Trial of Ambisome Given Alone and Ambisome Given in Combination With Miltefosine for the Treatment of VL HIV Positive Ethiopian Patients.

Role: collaborator

NCT02444598Not ApplicableCompleted

Trial of Negative-pressure Wound Therapy Use in Conflict-related Extremity Wounds

Role: collaborator

NCT01360762Phase 3Completed

Prophylaxis of Visceral Leishmaniasis Relapses in HIV Co-infected Patients With Pentamidine: a Cohort Study

Role: collaborator